In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
212 News Items found
Physician standing in front of a whiteboard
Finding
Novel Drug Advancing to Phase II Basket Trial of Solid Tumors

Learn more about entrectinib, a targeted therapy being evaluated in patients with solid tumors.
Postdocs Francisco “Pancho” Barriga and Kaloyan Tsanov in the lab
New MACHETE Technique Slices Into Cancer Genome To Study Copy Number Alterations

Learn why MSK researchers developed MACHETE, a new CRISPR-based technique to study large-scale genetic deletions efficiently in laboratory models.
wordfall
Poetry in Motion: The Meaning behind the Stunning Sculpture at MSK’s Josie Robertson Surgery Center

Discover the significance of the Josie Robertson Surgery Center’s signature art piece.
Surgeon-scientist Vinod Balachandran in the laboratory
Q&A
What To Know About Pancreatic Cancer

Learn about important advances in the treatment of pancreatic cancer.
Dr. Eileen O'Reilly seen with MSK nurse Tiffany Upshaw.
New KRAS Targeted Therapy Shows Promise Against Pancreatic Cancer

Learn how a new drug shows great promise for treating pancreatic by targeting the KRAS mutation, which fuels 90% of the disease.
A microscopic view of genetically engineered mouse tumor and a human FL-HCC tumor
In the Lab
With Help of CRISPR, Scientists Unravel the Cause of a Rare Liver Cancer

A team led by MSK molecular biologist Scott Lowe is making progress against fibrolamellar hepatocellular carcinoma.
Illustration of a magnifying glass and DNA sequences
Finding
Machine Learning May Help Classify Cancers of Unknown Primary

MSK investigators report a new tool that may help them determine the origin of some metastatic tumors, potentially leading to better targeted treatments.
Dr. Shanu Modi speaks with a patient
In the Clinic
FDA Approves Trastuzumab Deruxtecan (T-DXd) for Early-Stage HER2-Positive Breast Cancer

The FDA has approved trastuzumab deruxtecan (T-DXd, Enhertu) for treating early-stage, HER2-positive breast cancer based in part on clinical research led by MSK breast medical oncologist Shanu Modi, MD.
Tumor mutation model
Finding
Tumor Mutational Burden Can Help Predict Response to Immunotherapy in Many Different Cancers

Investigators confirmed that people whose tumors have a high tumor mutational burden and were treated with immunotherapy lived longer.
MSK robotic Whipple patient Chris Scott and his wife, Kathy
Robotic Whipple Surgery Helps Chris Beat Pancreatic Cancer — Before It Started

When Chris Scott met with his urologist in January 2022, he thought they’d talk about an issue he was having with his prostate. But the conversation to...